Clinical Trial Update: Remicade in the Treatment of Patients With Active Ankylosing Spondylitis

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating infliximab (Remicade) in patients with active ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Göteborg University | Conditions: Ankylosing Spondylitis | Status: COMPLETED